ArticleNutrition & metabolism2026
Association between DASH diet adherence and mortality in non-diabetic adults with and without chronic kidney disease.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe Dietary Approaches to Stop Hypertension (DASH) diet has been associated with reduced cardiovascular risk, but its impact on mortality in individuals with chronic kidney disease (CKD) remains uncertain.
methodsWe analyzed data from 37,827 adults in the NHANES 1999–2014 cycles (without diabetes). Participants were stratified by CKD status (eGFR < 60 mL/min/1.73 m²) and DASH adherence (above or below median score). Mortality outcomes were assessed via the National Death Index. Multivariable Cox regression models, adjusted for demographics, comorbidities, and diet, were used to evaluate associations with all-cause, cardiovascular (CV), and cancer mortality.
resultsHigh DASH adherence was associated with healthier metabolic profiles and lower blood pressure. Among non-CKD participants, higher DASH scores were linked to significantly lower composite CV or cancer mortality (HR 0.896; 95% CI, 0.806–0.997; p = 0.0431), but not to all-cause, CV, or cancer mortality individually. No significant mortality associations were observed in participants with CKD, and interaction effects between DASH and CKD status were non-significant. Higher intake of dietary fiber, magnesium, and potassium was associated with reduced mortality in the overall and non-CKD populations. However, in CKD participants, high magnesium and potassium intake were paradoxically associated with increased cancer mortality.
conclusionGreater adherence to the DASH diet is associated with lower CV and cancer-related mortality among individuals without CKD. In CKD patients, the benefits are less clear, and some nutrients may have differential effects. Personalized dietary strategies based on kidney function may be warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.